The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Editas Medicine, Inc(NASDAQ:EDIT) 
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary genome editing platform based on CRISPR technology to target genetically addressable diseases and therapeutic areas. ...
Website: http://www.editasmedicine.com
Founded: 2013
Full Time Employees: 208
Sector: Healthcare
Industry: Biotechnology
Editas Medicine Days Payable Outstanding ttm (DPO)
Editas Medicine Days Receivable Outstanding ttm (DSO)
Editas Medicine Days Inventory Outstanding ttm (DIO)
Editas Medicine Op Cashflow Per Share ttm
Editas Medicine Free Cashflow Per Share ttm
Editas Medicine Cash Per Share ttm
Editas Medicine P/S ratio ttm
Editas Medicine (GAAP) P/E ratio ttm
Editas Medicine P/B ratio ttm
No extra charts and metrics for this ticker.